Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer.
暂无分享,去创建一个
M. Gore | S. Kaye | T. Yap | Susana Banerjee | C. Gourley | D. Tan | P. Roxburgh | E. Grzybowska | J. Ang | M. Hutka | S. Banerjee